{"Title": ["3 \u201cStrong Buy\u201d Biotech Stocks Under $5 With Explosive Upside Potential", "BUZZ-U.S. STOCKS ON THE MOVE-Alliance Data Systems, Alibaba Group, Dexcom, Can Fite Biofarma, U.S. travel firms", "Health Care Sector Update for 12/13/2019: SRPT, BLRX, EXEL, JNJ, PFE, ABT, MRK, AMGN", "Health Care Sector Update for 03/27/2019: AXSM, BLRX, WCG, CNC, JNJ, PFE, ABT, MRK, AMGN", "Health Care Sector Update for 02/04/2019: BLRX, EOLS, FENC, JNJ, PFE, ABT, MRK, AMGN", "Wall Street Wavers Ahead of Opening Bell, Earnings on Tap", "US Futures Flat Ahead of Earnings", "Health Care Sector Update for 02/04/2019: ABMD,OMCL,BLRX,ABBV,BLK", "3 \u201cStrong Buy\u201d Biotech Stocks Under $5 With Explosive Upside Potential", "Can The Uptrend Continue for BioLineRx (BLRX)?", "BioLineRx (BLRX) in Focus: Stock Moves 7.5% Higher", "BioLineRx Stock Up on Stake Increase in Lead Cancer Program", "Portola's (PTLA) Lymphoma Candidate Gets Orphan Drug Status", "BioLineRx (BLRX) Continue to Surge Higher?", "Pre-Market Earnings Report for August 13, 2018 : SYY, TSG, HQCL, JKS, BLRX, EAST, SPCB", "CTI BioPharma Tanks Post Type B Talks on Pacritinib With FDA", "Health Care Sector Update for 11/20/2018: ORPN, BLRX, BSX, JNJ, PFE, ABT, MRK, AMGN", "Aclaris' Alopecia Candidate Gets Fast Track Designation", "Aclaris Stock Up on JAK Inhibitor's Encouraging Activity", "BioLineRx Sees Hammer Chart Pattern: Time to Buy?", "Shire (SHPG) HAE Drug Gets FDA Nod for Pediatric Population", "Moving Average Crossover Alert: BioLineRx Ltd. (BLRX)", "Health Care Sector Update for 01/23/2018: JNJ, PFE, ABT, MRK, AMGN, TNXP, VYGR, BLRX, AMGN, CELG", "BioLineRx Cancer Drug Positive as Monotherapy in Phase IIa", "VIVUS' PAH Candidate Data Positive in Early Stage Study", "Aclaris' Alopecia Candidate Gets Fast Track Designation", "Aclaris Stock Up on JAK Inhibitor's Encouraging Activity", "BioLine Rx (BLRX) Catches Eye: Stock Adds 5.2% in Session", "BioLineRx/Roche Scan BL-8040-Tecentriq for Pancreatic Cancer", "BioLineRx Makes Regulatory Submission for Trial of BL-8040", "3 Cheap Biotech Stocks The Big Boys Are Buying (BLRX, OMED, FWP)", "Health Care Sector Update for 01/17/2018: JNJ, PFE, ABT, MRK, AMGN, AEZS, JUNO, CELG, BLRX, CRIS, HOLX", "BioLineRx (BLRX) Starts Cancer Study on BL-8040+Keytruda", "Health Care Sector Update for 09/23/2016: ACHN,BLRX,APRI", "BioLineRx Begins Trial on BL-8040/ Keytruda Combination", "Health Care Sector Update for 09/08/2016: BLRX, APRI, JNJ, PFE, ABT, MRK, AMGN", "Pre-Market Earnings Report for May 17, 2016 : HD, TJX, MOMO, PLCE, RRGB, CYRN, DCIX, BLRX, PTN, ETAK, TISA, HOTR", "Bioline RX (BLRX) Shares March Higher, Can It Continue?", "BioLineRx (BLRX) Worth Watching: Stock Rises 11.3%", "Pre-Market Earnings Report for March 23, 2017 : ACN, CAG, CMC, AAAP, SCHL, HQCL, PIRS, BLRX, CGIX", "BioLineRx (BLRX) Starts Cancer Study on BL-8040+Keytruda", "Health Care Sector Update for 09/23/2016: ACHN,BLRX,APRI", "BioLineRx Begins Trial on BL-8040/ Keytruda Combination", "Pre-Market Earnings Report for August 20, 2015 : TTC, LANC, BKE, TECD, WUBA, CYBX, OSIS, AMWD, BLRX, RGS, RAVN, SSI", "BioLineRx Up on Phase IIb Study Initiation on Leukemia Drug", "Closing Update: U.S. Stocks Join in Global Slump For Equities; Energy, Technology Companies Again Lead Declines", "Health Care Sector Update for 07/27/2015: MAG,CMCO,NYMX,BLPH,BLRX", "Pre-Market Earnings Report for November 16, 2015 : JD, DDS, DPRX, EPRS, ANY, ARGS, BLRX, SORL, PPSI, MDLY, ASUR, FSNN", "BioLineRx (BLRX) Shows Strength: Stock Rises 7.4% - Tale of the Tape", "Pre-Market Earnings Report for May 18, 2015 : WPC, JASO, RLGT, BLRX", "BioLineRx (BLRX) Looks Good: Stock Moves 9.1% Higher - Tale of the Tape", "Health Care Sector Update for 03/25/2015: BLRX,VBLT,LPTN", "Pre-Market Earnings Report for March 23, 2015 : SVA, GPRK, BLRX", "Health Care Sector Update for 03/06/2015: BLRX,ICEL,AEZS", "BioLineRx (BLRX) Looks Good: Stock Adds 15.6% in Session - Tale of the Tape", "Health Care Sector Update for 07/27/2015: BLRX,NYMX,MGLN", "3 Pharmaceutical Stocks Set for Massive Earnings Growth in 2015 - Stocks in the News", "Zacks Rank #1 Additions for Tuesday - Tale of the Tape", "Zacks Rank #1 Additions for Tuesday - Tale of the Tape", "Zacks Rank #1 Additions for Wednesday - Tale of the Tape", "Zacks Rank #1 Additions for Tuesday - Tale of the Tape", "Closing Update: Late Bounce Carries Stocks to Second Positive Day in a Row; Tech Shares Pace Advance", "Health Care Sector Update for 01/20/2015: VBLT,ACOR,BLRX,PETS,MDWD", "Can The Uptrend Continue for BioLineRx (BLRX)? - Tale of the Tape", "BioLineRx Finishes Dose-Escalation in Phase I BL-8040 Study - Analyst Blog", "BioLineRx Out-Licences Skin Lesion Treatment Candidate - Analyst Blog", "Health Care Sector Update for 12/08/2014: BLRX,CBST,MRK,ALR", "Sector Update: Health Care", "Sector Update: Health-Care Shares Higher Pre-Market", "BioLineRx to Commence BL-8040 Study - Analyst Blog", "Sector Update: Healthcare Shares Flat Pre-Market; Bioline Q1 Net Loss Narrows", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Update on BioLineRx's BL-8040 - Analyst Blog", "IntelliPharmaCeutics International (IPCI) Soars: Stock Rises 9.1% - Tale of the Tape", "BioLineRx Reports Narrower 2013 Loss - Analyst Blog", "Pre-Market Earnings Report for March 17, 2014 : INO, JASO, ACRE, TNP, LMIA, HNR, STRL, BLRX", "Pipeline Update at BioLineRx - Analyst Blog", "IntelliPharmaCeutics (IPCI) Jumps: Stock Up 8.9% - Tale of the Tape", "Portola Pharmaceuticals (PTLA) Jumps: Stock Up 8.3% - Tale of the Tape", "Sector Update: Healthcares", "Data on BioLineRx's BL-8040 - Analyst Blog", "Update on BioLineRx' BL-8040 - Analyst Blog", "Update on BioLineRx's BL-5010 - Analyst Blog", "BioLineRx Progresses with BL-8040 - Analyst Blog", "BioLineRx-JHL Biotech Collaborate - Analyst Blog", "Update on BioLineRx's BL-7010 - Analyst Blog", "Initial Results on BioLineRx' BL-8040 - Analyst Blog", "Nektar Therapeutics (NKTR) Jumps: Stock Up 10.5% - Tale of the Tape", "Sector Update: Healthcare Shares Flat, Echo Therapeutics Spikes 30% on Glucose Monitoring System Meeting Primary Endpoints", "Sector Update: Healthcare", "BioLineRx's Pipeline Holds Promise - Analyst Blog", "Good News for BioLineRx - Analyst Blog", "U.S. Patent Allowance for BioLineRx' BL-8020 - Analyst Blog", "Sector Update: Healthcare Shares Flat; Agenus Rallies 22% on Phase 2 Cancer Treatment Study", "Sector Update: Healthcare", "New Data on BioLineRx BL-7040 - Analyst Blog", "New U.S. Patent for BiolineRx's BL-8040 - Analyst Blog", "Data on BioLineRx' BL-8040 - Analyst Blog", "BioLineRx Enrolls First Patient in Study - Analyst Blog", "Positive Data on BioLineRx Treatment - Analyst Blog", "BioLineRx to Start BL-8040 Study - Analyst Blog", "Pipeline Setback at BioLineRx - Analyst Blog", "BioLineRx to Initiate HCV Study - Analyst Blog", "Orphan Status for BioLineRx' Candidate - Analyst Blog", "3 Biopharma Catalyst Trades To Consider For Today"], "Elapsed Time": ["MAY 27, 2020", "MAY 26, 2020", "DEC 13, 2019", "MAR 27, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "FEB 4, 2019", "MAY 27, 2020", "OCT 8, 2018", "OCT 5, 2018", "OCT 4, 2018", "SEP 26, 2018", "SEP 21, 2018", "AUG 10, 2018", "JUL 19, 2018", "NOV 20, 2018", "JUL 10, 2018", "JUL 6, 2018", "JUN 29, 2018", "JUN 22, 2018", "APR 3, 2018", "JAN 23, 2018", "JAN 18, 2018", "JUL 11, 2018", "JUL 10, 2018", "JUL 6, 2018", "JUL 21, 2017", "JUL 11, 2017", "MAY 23, 2017", "MAY 15, 2017", "JAN 17, 2018", "JAN 19, 2017", "SEP 23, 2016", "SEP 21, 2016", "SEP 8, 2016", "MAY 16, 2016", "DEC 4, 2015", "DEC 2, 2015", "MAR 22, 2017", "JAN 19, 2017", "SEP 23, 2016", "SEP 21, 2016", "AUG 19, 2015", "AUG 18, 2015", "JUL 27, 2015", "JUL 27, 2015", "NOV 13, 2015", "JUN 24, 2015", "MAY 15, 2015", "MAR 25, 2015", "MAR 25, 2015", "MAR 20, 2015", "MAR 6, 2015", "MAR 4, 2015", "JUL 27, 2015", "MAR 2, 2015", "FEB 24, 2015", "FEB 17, 2015", "FEB 11, 2015", "FEB 3, 2015", "JAN 20, 2015", "JAN 20, 2015", "MAR 4, 2015", "JAN 8, 2015", "DEC 26, 2014", "DEC 8, 2014", "AUG 21, 2014", "AUG 21, 2014", "JUN 19, 2014", "MAY 20, 2014", "JAN 19, 2015", "APR 11, 2014", "MAR 21, 2014", "MAR 18, 2014", "MAR 14, 2014", "MAR 12, 2014", "MAR 11, 2014", "MAR 5, 2014", "MAY 20, 2014", "FEB 13, 2014", "JAN 27, 2014", "JAN 22, 2014", "JAN 16, 2014", "JAN 13, 2014", "DEC 20, 2013", "DEC 17, 2013", "MAR 4, 2014", "NOV 26, 2013", "NOV 26, 2013", "NOV 22, 2013", "OCT 8, 2013", "SEP 19, 2013", "SEP 17, 2013", "SEP 17, 2013", "NOV 27, 2013", "SEP 5, 2013", "AUG 8, 2013", "JUN 7, 2013", "APR 18, 2013", "APR 16, 2013", "MAR 25, 2013", "MAR 15, 2013", "SEP 10, 2013", "FEB 6, 2013"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/3-strong-buy-biotech-stocks-under-%245-with-explosive-upside-potential-2020-05-27", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-alliance-data-systems-alibaba-group-dexcom-can-fite-biofarma", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-13-2019%3A-srpt-blrx-exel-jnj-pfe-abt-mrk-amgn-2019-12-13", "https://www.nasdaq.com/articles/health-care-sector-update-03272019-axsm-blrx-wcg-cnc-jnj-pfe-abt-mrk-amgn-2019-03-27", "https://www.nasdaq.com/articles/health-care-sector-update-02042019-blrx-eols-fenc-jnj-pfe-abt-mrk-amgn-2019-02-04", "https://www.nasdaq.com/articles/wall-street-wavers-ahead-opening-bell-earnings-tap-2019-02-04", "https://www.nasdaq.com/articles/us-futures-flat-ahead-earnings-2019-02-04", "https://www.nasdaq.com/articles/health-care-sector-update-02042019-abmdomclblrxabbvblk-2019-02-04", "https://www.nasdaq.com/articles/3-strong-buy-biotech-stocks-under-%245-with-explosive-upside-potential-2020-05-27", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-biolinerx-blrx-2018-10-08", "https://www.nasdaq.com/articles/biolinerx-blrx-in-focus%3A-stock-moves-7.5-higher-2018-10-05", "https://www.nasdaq.com/articles/biolinerx-stock-up-on-stake-increase-in-lead-cancer-program-2018-10-04", "https://www.nasdaq.com/articles/portolas-ptla-lymphoma-candidate-gets-orphan-drug-status-2018-09-26", "https://www.nasdaq.com/articles/biolinerx-blrx-continue-to-surge-higher-2018-09-21", "https://www.nasdaq.com/articles/pre-market-earnings-report-august-13-2018-syy-tsg-hqcl-jks-blrx-east-spcb-2018-08-10", "https://www.nasdaq.com/articles/cti-biopharma-tanks-post-type-b-talks-on-pacritinib-with-fda-2018-07-19", "https://www.nasdaq.com/articles/health-care-sector-update-11202018-orpn-blrx-bsx-jnj-pfe-abt-mrk-amgn-2018-11-20", "https://www.nasdaq.com/articles/aclaris-alopecia-candidate-gets-fast-track-designation-2018-07-10", "https://www.nasdaq.com/articles/aclaris-stock-up-on-jak-inhibitors-encouraging-activity-2018-07-06", "https://www.nasdaq.com/articles/biolinerx-sees-hammer-chart-pattern%3A-time-to-buy-2018-06-29", "https://www.nasdaq.com/articles/shire-shpg-hae-drug-gets-fda-nod-for-pediatric-population-2018-06-22", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-biolinerx-ltd.-blrx-2018-04-03", "https://www.nasdaq.com/articles/health-care-sector-update-01232018-jnj-pfe-abt-mrk-amgn-tnxp-vygr-blrx-amgn-celg-2018-01", "https://www.nasdaq.com/articles/biolinerx-cancer-drug-positive-as-monotherapy-in-phase-iia-2018-01-18", "https://www.nasdaq.com/articles/vivus-pah-candidate-data-positive-in-early-stage-study-2018-07-11", "https://www.nasdaq.com/articles/aclaris-alopecia-candidate-gets-fast-track-designation-2018-07-10", "https://www.nasdaq.com/articles/aclaris-stock-up-on-jak-inhibitors-encouraging-activity-2018-07-06", "https://www.nasdaq.com/articles/bioline-rx-blrx-catches-eye%3A-stock-adds-5.2-in-session-2017-07-21", "https://www.nasdaq.com/articles/biolinerx-roche-scan-bl-8040-tecentriq-for-pancreatic-cancer-2017-07-11", "https://www.nasdaq.com/articles/biolinerx-makes-regulatory-submission-for-trial-of-bl-8040-2017-05-23", "https://www.nasdaq.com/articles/3-cheap-biotech-stocks-the-big-boys-are-buying-blrx-omed-fwp-2017-05-15", "https://www.nasdaq.com/articles/health-care-sector-update-01172018-jnj-pfe-abt-mrk-amgn-aezs-juno-celg-blrx-cris-holx-2018", "https://www.nasdaq.com/articles/biolinerx-blrx-starts-cancer-study-on-bl-8040keytruda-2017-01-19", "https://www.nasdaq.com/articles/health-care-sector-update-09232016-achnblrxapri-2016-09-23", "https://www.nasdaq.com/articles/biolinerx-begins-trial-on-bl-8040-keytruda-combination-2016-09-21", "https://www.nasdaq.com/articles/health-care-sector-update-09082016-blrx-apri-jnj-pfe-abt-mrk-amgn-2016-09-08", "https://www.nasdaq.com/articles/pre-market-earnings-report-may-17-2016-hd-tjx-momo-plce-rrgb-cyrn-dcix-blrx-ptn-etak-tisa", "https://www.nasdaq.com/articles/bioline-rx-blrx-shares-march-higher-can-it-continue-2015-12-04", "https://www.nasdaq.com/articles/biolinerx-blrx-worth-watching%3A-stock-rises-11.3-2015-12-02", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-23-2017-acn-cag-cmc-aaap-schl-hqcl-pirs-blrx-cgix-2017-03", "https://www.nasdaq.com/articles/biolinerx-blrx-starts-cancer-study-on-bl-8040keytruda-2017-01-19", "https://www.nasdaq.com/articles/health-care-sector-update-09232016-achnblrxapri-2016-09-23", "https://www.nasdaq.com/articles/biolinerx-blrx-shares-march-higher-can-it-continue-2015-09-04", "https://www.nasdaq.com/articles/pre-market-earnings-report-august-20-2015-ttc-lanc-bke-tecd-wuba-cybx-osis-amwd-blrx-rgs", "https://www.nasdaq.com/articles/biolinerx-up-on-phase-iib-study-initiation-on-leukemia-drug-2015-08-18", "https://www.nasdaq.com/articles/closing-update-us-stocks-join-global-slump-equities-energy-technology-companies-again-lead", "https://www.nasdaq.com/articles/health-care-sector-update-07272015-magcmconymxblphblrx-2015-07-27", "https://www.nasdaq.com/articles/pre-market-earnings-report-november-16-2015-jd-dds-dprx-eprs-any-args-blrx-sorl-ppsi-mdly", "https://www.nasdaq.com/articles/biolinerx-blrx-shows-strength%3A-stock-rises-7.4-tale-of-the-tape-2015-06-24", "https://www.nasdaq.com/articles/pre-market-earnings-report-may-18-2015-wpc-jaso-rlgt-blrx-2015-05-15", "https://www.nasdaq.com/articles/biolinerx-blrx-looks-good%3A-stock-moves-9.1-higher-tale-of-the-tape-2015-03-25", "https://www.nasdaq.com/articles/health-care-sector-update-03252015-blrxvbltlptn-2015-03-25", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-23-2015-sva-gprk-blrx-2015-03-20", "https://www.nasdaq.com/articles/health-care-sector-update-03062015-blrxicelaezs-2015-03-06", "https://www.nasdaq.com/articles/biolinerx-blrx-looks-good%3A-stock-adds-15.6-in-session-tale-of-the-tape-2015-03-04", "https://www.nasdaq.com/articles/health-care-sector-update-07272015-blrxnymxmgln-2015-07-27", "https://www.nasdaq.com/articles/3-pharmaceutical-stocks-set-massive-earnings-growth-2015-stocks-news-2015-03-02", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-tuesday-tale-of-the-tape-2015-02-24", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-tuesday-tale-of-the-tape-2015-02-17", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-wednesday-tale-of-the-tape-2015-02-11", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-tuesday-tale-of-the-tape-2015-02-03", "https://www.nasdaq.com/articles/closing-update-late-bounce-carries-stocks-second-positive-day-row-tech-shares-pace-advance", "https://www.nasdaq.com/articles/health-care-sector-update-01202015-vbltacorblrxpetsmdwd-2015-01-20", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-biolinerx-blrx-tale-of-the-tape-2015-03-04", "https://www.nasdaq.com/articles/biolinerx-finishes-dose-escalation-in-phase-i-bl-8040-study-analyst-blog-2015-01-08", "https://www.nasdaq.com/articles/biolinerx-out-licences-skin-lesion-treatment-candidate-analyst-blog-2014-12-26", "https://www.nasdaq.com/articles/health-care-sector-update-12082014-blrxcbstmrkalr-2014-12-08", "https://www.nasdaq.com/articles/sector-update-health-care-2014-08-21", "https://www.nasdaq.com/articles/sector-update-health-care-shares-higher-pre-market-2014-08-21", "https://www.nasdaq.com/articles/biolinerx-to-commence-bl-8040-study-analyst-blog-2014-06-19", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-pre-market-bioline-q1-net-loss-narrows-2014-05-20", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2015-01-19", "https://www.nasdaq.com/articles/update-on-biolinerxs-bl-8040-analyst-blog-2014-04-11", "https://www.nasdaq.com/articles/intellipharmaceutics-international-ipci-soars%3A-stock-rises-9.1-tale-of-the-tape-2014-03-21", "https://www.nasdaq.com/articles/biolinerx-reports-narrower-2013-loss-analyst-blog-2014-03-18", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-17-2014-ino-jaso-acre-tnp-lmia-hnr-strl-blrx-2014-03-14", "https://www.nasdaq.com/articles/pipeline-update-at-biolinerx-analyst-blog-2014-03-12", "https://www.nasdaq.com/articles/intellipharmaceutics-ipci-jumps%3A-stock-up-8.9-tale-of-the-tape-2014-03-11", "https://www.nasdaq.com/articles/portola-pharmaceuticals-ptla-jumps%3A-stock-up-8.3-tale-of-the-tape-2014-03-05", "https://www.nasdaq.com/articles/sector-update-healthcares-2014-05-20", "https://www.nasdaq.com/articles/data-on-biolinerxs-bl-8040-analyst-blog-2014-02-13", "https://www.nasdaq.com/articles/update-on-biolinerx-bl-8040-analyst-blog-2014-01-27", "https://www.nasdaq.com/articles/update-on-biolinerxs-bl-5010-analyst-blog-2014-01-22", "https://www.nasdaq.com/articles/biolinerx-progresses-with-bl-8040-analyst-blog-2014-01-16", "https://www.nasdaq.com/articles/biolinerx-jhl-biotech-collaborate-analyst-blog-2014-01-13", "https://www.nasdaq.com/articles/update-on-biolinerxs-bl-7010-analyst-blog-2013-12-20", "https://www.nasdaq.com/articles/initial-results-on-biolinerx-bl-8040-analyst-blog-2013-12-17", "https://www.nasdaq.com/articles/nektar-therapeutics-nktr-jumps%3A-stock-up-10.5-tale-of-the-tape-2014-03-04", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-echo-therapeutics-spikes-30-glucose-monitoring-system", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-11-26-1", "https://www.nasdaq.com/articles/biolinerxs-pipeline-holds-promise-analyst-blog-2013-11-22", "https://www.nasdaq.com/articles/good-news-for-biolinerx-analyst-blog-2013-10-08", "https://www.nasdaq.com/articles/u.s.-patent-allowance-for-biolinerx-bl-8020-analyst-blog-2013-09-19", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-agenus-rallies-22-phase-2-cancer-treatment-study-2013", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-09-17-1", "https://www.nasdaq.com/articles/new-data-on-biolinerx-bl-7040-analyst-blog-2013-11-27", "https://www.nasdaq.com/articles/new-u.s.-patent-for-biolinerxs-bl-8040-analyst-blog-2013-09-05", "https://www.nasdaq.com/articles/data-on-biolinerx-bl-8040-analyst-blog-2013-08-08", "https://www.nasdaq.com/articles/biolinerx-enrolls-first-patient-in-study-analyst-blog-2013-06-07", "https://www.nasdaq.com/articles/positive-data-on-biolinerx-treatment-analyst-blog-2013-04-18", "https://www.nasdaq.com/articles/biolinerx-to-start-bl-8040-study-analyst-blog-2013-04-16", "https://www.nasdaq.com/articles/pipeline-setback-at-biolinerx-analyst-blog-2013-03-25", "https://www.nasdaq.com/articles/biolinerx-to-initiate-hcv-study-analyst-blog-2013-03-15", "https://www.nasdaq.com/articles/orphan-status-for-biolinerx-candidate-analyst-blog-2013-09-10", "https://www.nasdaq.com/articles/3-biopharma-catalyst-trades-consider-today-2013-02-06"], "Content": []}